AMAL (Amalgamated Financial) Research & Development: $0.0 Mil (TTM As of Mar. 2026)


AMAL Amalgamated Financial Corp AMAL
66 GF Score
Price $45.80
GF Value $33.06
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Amalgamated Financial Research & Development?

Amalgamated Financial AMAL +0.66% 66 Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus rates AMAL with a GF Score™ of 66/100 and a GF Value™ of $33.06 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Amalgamated Financial's Research & Development for the three months ended in Mar. 2026 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was $0.0 Mil.

Amalgamated Financial  (NAS:AMAL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Amalgamated Financial Research & Development Related Terms

Amalgamated Financial Research & Development Historical Data

* Premium members only.

The historical data trend for Amalgamated Financial's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amalgamated Financial Research & Development Chart

Amalgamated Financial Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Amalgamated Financial Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
AMAL
66GF Score
Amalgamated Financial Corp AMAL
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Amalgamated Financial Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
Amalgamated Financial (AMAL) has a Research & Development of $0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Amalgamated Financial and its competitors.
Is Amalgamated Financial's Research & Development too high?
Amalgamated Financial's current Research & Development is $0.0 Mil. Overall, Amalgamated Financial has a GF Score™ of 66/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Amalgamated Financial's Research & Development compare to TMP and PEBO?
Amalgamated Financial's Research & Development of $0.0 Mil can be compared against companies in the Banks industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Banks company?
A good Research & Development depends on the Banks industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Amalgamated Financial and its competitors. Amalgamated Financial's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amalgamated Financial stock overvalued right now?
Based on GuruFocus' analysis, Amalgamated Financial (AMAL) is currently considered Significantly Overvalued. The stock's GF Value™ is $33.06, compared to a current price of $45.80 — trading 38.5% above its estimated fair value. The current Research & Development is $0.0 Mil. Amalgamated Financial's overall GF Score™ is 66/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Amalgamated Financial (AMAL), the current Research & Development is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Amalgamated Financial (AMAL) Overvalued in 2026?

Based on GuruFocus' analysis, Amalgamated Financial stock appears to be overvalued. The current stock price of $45.80 is trading 38.5% above its estimated GF Value™ of $33.06. GuruFocus considers Amalgamated Financial to be Significantly Overvalued.

Key valuation signals for AMAL:

  • Research & Development: $0.0 Mil
  • GF Value™: $33.06 vs. price of $45.80 (38.5% above fair value)
  • GF Score™: 66/100 with 7 warning signs

No single metric tells the full story. See the AMAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Amalgamated Financial Business Description

Other Exchanges A0B0:Germany
Address 275 Seventh Avenue, New York, NY, USA, 10001
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management, and trust and custody services.
66GF Score

Get the complete analysis for AMAL

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$45.80
Price
$33.06
GF Value